52 min

MAPS Roundtable on DEA Rescheduling of Cannabis The Green Rush is real.

    • News - Affari

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.



This week’s episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA’s proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of Communications & Post-Prohibition Strategy at MAPS, Karen O’Keefe, Director of State Policies at Marijuana Policy Project (MPP) and Paul Armentano, Deputy Director at NORML. 



With the unprecedented federal drug policy change on the near horizon, MAPS assembled leaders with more than 50 years of combined experience in the cannabis policy reform movement to talk about what these changes are, why they matter, what myths need debunking, and what still needs to be done. Some of the topics covered in this conversation include the impact rescheduling will have on research and development of cannabis-based medicines, criminal law and systems-impacted people, cannabis banking and interstate commerce and veteran affairs. 



If you are interested in learning more about how MAPS, MPP or NORML have played pivotal roles in implementing drug policy reform over the decades, be sure to follow them all on their socials linked in our show notes and visit their websites to follow their advocacy work.  



So, sit back and enjoy this crossover Q&A discussion on the future of cannabis drug policy. 



Links and mentions in the show



https://maps.org/ 

https://norml.org/ 

https://www.mpp.org/ 



Links to the guest’s company and social media accounts



Betty Aldworth LinkedIn: https://www.linkedin.com/in/bettyaldworth/ 

Karen O’Keefe LinkedIn: https://www.linkedin.com/in/karen-o-keefe-255a9921a/ 

NORML LinkedIn: https://www.linkedin.com/company/norml/ 

MPP Twitter: https://twitter.com/marijuanapolicy 

NORML Twitter: https://twitter.com/NORML 

MAPS Twitter: https://twitter.com/maps 



Show Credits:



This episode was hosted by Anne Donohoe of KCSA Strategic Communications.



Special thanks to our Program Director, Shea Gunther and to the MAPS team. 



You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



X: @KCSAPodcastLabs



Instagram: @KCSAPodcastLabs



LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.



This week’s episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA’s proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of Communications & Post-Prohibition Strategy at MAPS, Karen O’Keefe, Director of State Policies at Marijuana Policy Project (MPP) and Paul Armentano, Deputy Director at NORML. 



With the unprecedented federal drug policy change on the near horizon, MAPS assembled leaders with more than 50 years of combined experience in the cannabis policy reform movement to talk about what these changes are, why they matter, what myths need debunking, and what still needs to be done. Some of the topics covered in this conversation include the impact rescheduling will have on research and development of cannabis-based medicines, criminal law and systems-impacted people, cannabis banking and interstate commerce and veteran affairs. 



If you are interested in learning more about how MAPS, MPP or NORML have played pivotal roles in implementing drug policy reform over the decades, be sure to follow them all on their socials linked in our show notes and visit their websites to follow their advocacy work.  



So, sit back and enjoy this crossover Q&A discussion on the future of cannabis drug policy. 



Links and mentions in the show



https://maps.org/ 

https://norml.org/ 

https://www.mpp.org/ 



Links to the guest’s company and social media accounts



Betty Aldworth LinkedIn: https://www.linkedin.com/in/bettyaldworth/ 

Karen O’Keefe LinkedIn: https://www.linkedin.com/in/karen-o-keefe-255a9921a/ 

NORML LinkedIn: https://www.linkedin.com/company/norml/ 

MPP Twitter: https://twitter.com/marijuanapolicy 

NORML Twitter: https://twitter.com/NORML 

MAPS Twitter: https://twitter.com/maps 



Show Credits:



This episode was hosted by Anne Donohoe of KCSA Strategic Communications.



Special thanks to our Program Director, Shea Gunther and to the MAPS team. 



You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



X: @KCSAPodcastLabs



Instagram: @KCSAPodcastLabs



LinkedIn: linkedin.com/company/thegreenrushpodcast

52 min